European Journal of Obstetrics & Gynecology and Reproductive Biology
Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks’ gestation: Audit in a tertiary referral center
Introduction
Severe, very early onset preeclampsia is associated with high mortality and morbidity for both mother and child. Although the etiology of preeclampsia is unknown [1], delivery of the fetus and placenta is the only way of arresting this serious disease. Delivery may benefit the mother but is not in the interest of the fetus, if remote from term. The main cause of neonatal mortality and morbidity in patients with severe preeclampsia is prematurity [2]. Therefore, expectant or “conservative” management with temporizing treatment was introduced in order to lengthen gestation, which may be associated with enhanced perinatal survival. Expectant management of preeclampsia includes variable periods of using pharmacological agents for controlling hypertension with accurate, maternal hemodynamic monitoring and the prophylaxis of eclampsia by magnesium sulfate. Corticosteroids are administered to enhance fetal lung maturity. Maternal and fetal surveillance is conducted at regular intervals and delivery is indicated for worsening maternal and fetal conditions. Prolongation of pregnancy has been described with an average of 2 weeks [3], [4] with longer periods gained at earlier gestation [5], [6]. However, the number of reported patients with very early onset preeclampsia treated expectantly is very small [3], [4], [6], [7] Therefore, data remain limited on the maternal morbidity and mortality and on how many of these pregnancies will result in a take home baby. At our department a protocol of temporizing management of severe, early onset preeclampsia was instituted in 1985, consisting of volume expansion and vasodilatation guided by Swan Ganz catheter for continuous blood pressure measurements [4]. Since 1993 temporizing treatment was guided by a central venous line instead of a Swan Ganz catheter. In the present study all women with preeclampsia with an onset before 24 weeks’ gestation, admitted between 1993 and 2003, were evaluated for their maternal and perinatal outcome.
Section snippets
Materials and methods
From 1 January 1993 until 31 December 2002 information of all 26 consecutive women who had preeclamspia with an onset before 24 weeks’ gestation at the Erasmus Medical Center Rotterdam were recruited from a computer database and patient charts. Data were collected from 1993 since an automated database was available.
Preeclampsia was defined as blood pressure ≥140 mmHg systolic or ≥90 mmHg diastolic measured on at least two occasions in women normotensive before 20 weeks’ gestation and proteinuria
Results
During the 10-year study period, 14,212 women were delivered in the Erasmus Medical Center Rotterdam. Twenty-six women were admitted because of preeclampsia with an onset before 24 weeks’ gestation and therefore, eligible for the study. None of the patients was offered termination of pregnancy. The median prolongation of pregnancy was 24 days (range 3–46 days).
Discussion
We describe 26 pregnancies complicated by preeclampsia, admitted before 24 weeks’ gestation, managed expectantly. One maternal death occurred. This patient was actually not eligible for temporizing management because of her poor clinical condition at admission. At admission eight patients presented with severe morbidity (eight HELLP syndrome of which three in combination with eclampsia). After initiation of temporizing management another nine patients developed severe morbidity; eight patients
Acknowledgement
CJM de Groot is supported as “Clinical Fellow” by the Netherlands Organization for Scientific Research (NWO).
References (20)
- et al.
Pathogenesis and genetics of pre-eclampsia
Lancet
(2001) - et al.
Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term
Eur J Obstet Gynecol Reprod Biol
(1995) - et al.
Expectant management of severe pre-eclampsia in the mid-trimester
Eur J Obstet Gynecol Reprod Biol
(2001) - et al.
A protocol for managing severe preeclampsia in the second trimester
Am J Obstet Gynecol
(1990) - et al.
Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia
Eur J Obstet Gynecol Reprod Biol
(1994) - et al.
Urinary protein excretion and expectant management of early onset, severe pre-eclampsia
Int J Gynaecol Obstet
(2002) - et al.
Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis
Am J Obstet Gynecol
(1991) - et al.
Preeclampsia. Part 1. Clinical and pathophysiologic considerations
Obstet Gynecol Surv
(2002) - et al.
Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester
Am J Obstet Gynecol
(1985) - et al.
Conservative management of severe proteinuric hypertension before 28 weeks’ gestation
S Afr Med J
(1988)